{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:23:26Z","timestamp":1781529806059,"version":"3.54.1"},"reference-count":72,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"DOI":"10.1167\/tvst.8.5.15","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T14:30:32Z","timestamp":1568903432000},"page":"15","source":"Crossref","is-referenced-by-count":28,"title":["\u0394<sup>9<\/sup>-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits"],"prefix":"10.1167","volume":"8","author":[{"given":"Pranjal S.","family":"Taskar","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, MS, USA"},{"name":"Research Institute of Pharmaceutical Sciences, University of Mississippi, Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, MS, USA"},{"name":"Research Institute of Pharmaceutical Sciences, University of Mississippi, Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prit","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, MS, USA"},{"name":"Research Institute of Pharmaceutical Sciences, University of Mississippi, Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Ashour","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, MS, USA"},{"name":"Research Institute of Pharmaceutical Sciences, University of Mississippi, Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Gul","sequence":"additional","affiliation":[{"name":"ElSohly Laboratories Inc., Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"ElSohly","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, MS, USA"},{"name":"Research Institute of Pharmaceutical Sciences, University of Mississippi, Oxford, MS, USA"},{"name":"ElSohly Laboratories Inc., Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Murphy","sequence":"additional","affiliation":[{"name":"Emerald Bioscience Inc., Costa Mesa, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyajit","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, MS, USA"},{"name":"Research Institute of Pharmaceutical Sciences, University of Mississippi, Oxford, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"i2164-2591-8-5-15-b01","doi-asserted-by":"crossref","unstructured":"Quigley\n\t\t\t\t\t\t\tHA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAddicks\n\t\t\t\t\t\t\tEM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGreen\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaumenee\n\t\t\t\t\t\t\tAE.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tOptic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.\n\t\t\t\t\tArch Ophthalmol.\n\t\t\t\t\t1981;\n\t\t\t\t\t99:\n\t\t\t\t\t635\u2013649.","DOI":"10.1001\/archopht.1981.03930010635009"},{"key":"i2164-2591-8-5-15-b02","doi-asserted-by":"crossref","unstructured":"Abe\n\t\t\t\t\t\t\tRY,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDiniz-Filho\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCosta\n\t\t\t\t\t\t\tVP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGracitelli\n\t\t\t\t\t\t\tCPB,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaig\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMedeiros\n\t\t\t\t\t\t\tFA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma.\n\t\t\t\t\tOphthalmology.\n\t\t\t\t\t2016;\n\t\t\t\t\t123:\n\t\t\t\t\t552\u2013557.","DOI":"10.1016\/j.ophtha.2015.10.046"},{"key":"i2164-2591-8-5-15-b03","doi-asserted-by":"crossref","unstructured":"Cook\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFoster\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tEpidemiology of glaucoma: what's new?\n\t\t\t\t\tCan J Ophthalmol.\n\t\t\t\t\t2012;\n\t\t\t\t\t47:\n\t\t\t\t\t223\u2013226.","DOI":"10.1016\/j.jcjo.2012.02.003"},{"key":"i2164-2591-8-5-15-b04","doi-asserted-by":"crossref","unstructured":"Adelli\n\t\t\t\t\t\t\tGR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBhagav\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaskar\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tDevelopment of a delta9-tetrahydrocannabinol amino acid-dicarboxylate prodrug with improved ocular bioavailability.\n\t\t\t\t\tInvest Ophthalmol Vis Sci.\n\t\t\t\t\t2017;\n\t\t\t\t\t58:\n\t\t\t\t\t2167\u20132179.","DOI":"10.1167\/iovs.16-20757"},{"key":"i2164-2591-8-5-15-b05","doi-asserted-by":"crossref","unstructured":"Quigley\n\t\t\t\t\t\t\tHA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBroman\n\t\t\t\t\t\t\tAT.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe number of people with glaucoma worldwide in 2010 and 2020.\n\t\t\t\t\tBr J Ophthalmol.\n\t\t\t\t\t2006;\n\t\t\t\t\t90:\n\t\t\t\t\t262\u2013267.","DOI":"10.1136\/bjo.2005.081224"},{"key":"i2164-2591-8-5-15-b06","unstructured":"NEI.\n\t\t\t\t\tGlaucoma, Open-angle.\n\t\t\t\t\thttps:\/\/nei.nih.gov\/eyedata\/glaucoma"},{"key":"i2164-2591-8-5-15-b07","unstructured":"Gr\u00fcb\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMielke\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tAqueous humor dynamics [In German].\n\t\t\t\t\tOphthalmologe.\n\t\t\t\t\t2004;\n\t\t\t\t\t101:\n\t\t\t\t\t357\u2013365."},{"key":"i2164-2591-8-5-15-b08","doi-asserted-by":"crossref","unstructured":"Macri\n\t\t\t\t\t\t\tFJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCevario\n\t\t\t\t\t\t\tSJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe formation and inhibition of aqueous humor production: a proposed mechanism of action.\n\t\t\t\t\tArch Ophthalmol.\n\t\t\t\t\t1978;\n\t\t\t\t\t96:\n\t\t\t\t\t1664\u20131667.","DOI":"10.1001\/archopht.1978.03910060290023"},{"key":"i2164-2591-8-5-15-b09","doi-asserted-by":"crossref","unstructured":"Brubaker\n\t\t\t\t\t\t\tRF.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tGoldmann's equation and clinical measures of aqueous dynamics.\n\t\t\t\t\tExp Eye Res.\n\t\t\t\t\t2004;\n\t\t\t\t\t78:\n\t\t\t\t\t633\u2013637.","DOI":"10.1016\/j.exer.2003.07.002"},{"key":"i2164-2591-8-5-15-b10","doi-asserted-by":"crossref","unstructured":"Goel\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPicciani\n\t\t\t\t\t\t\tRG,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tRK,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBhattacharya\n\t\t\t\t\t\t\tSK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tAqueous humor dynamics: a review.\n\t\t\t\t\tOpen Ophthalmol J.\n\t\t\t\t\t2010;\n\t\t\t\t\t4:\n\t\t\t\t\t52\u201359.","DOI":"10.2174\/1874364101004010052"},{"key":"i2164-2591-8-5-15-b11","doi-asserted-by":"crossref","unstructured":"Gabelt\n\t\t\t\t\t\t\tBAT,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKaufman\n\t\t\t\t\t\t\tPL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tChanges in aqueous humor dynamics with age and glaucoma.\n\t\t\t\t\tProg Retin Eye Res.\n\t\t\t\t\t2005;\n\t\t\t\t\t24:\n\t\t\t\t\t612\u2013637.","DOI":"10.1016\/j.preteyeres.2004.10.003"},{"key":"i2164-2591-8-5-15-b12","doi-asserted-by":"crossref","unstructured":"Yablonski\n\t\t\t\t\t\t\tME,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZimmerman\n\t\t\t\t\t\t\tTJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWaltman\n\t\t\t\t\t\t\tSR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBecker\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tA fluorophotometric study of the effect of topical timolol on aqueous humor dynamics.\n\t\t\t\t\tExp Eye Res.\n\t\t\t\t\t1978;\n\t\t\t\t\t27:\n\t\t\t\t\t135\u2013142.","DOI":"10.1016\/0014-4835(78)90083-0"},{"key":"i2164-2591-8-5-15-b13","unstructured":"Tataru\n\t\t\t\t\t\t\tCP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPurcarea\n\t\t\t\t\t\t\tVL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tAntiglaucoma pharmacotherapy.\n\t\t\t\t\tJ Med Life\n\t\t\t\t\t2012;\n\t\t\t\t\t5:\n\t\t\t\t\t247\u2013251."},{"key":"i2164-2591-8-5-15-b14","doi-asserted-by":"crossref","unstructured":"Toris\n\t\t\t\t\t\t\tCB.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tPharmacology of aqueous humor formation A2.\n\t\t\t\t\tIn:\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDartt\n\t\t\t\t\t\t\tDA,\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\ted.\n\t\t\t\t\tEncyclopedia of the Eye.\n\t\t\t\t\tOxford:\n\t\t\t\t\tAcademic Press;\n\t\t\t\t\t2010:\n\t\t\t\t\t312\u2013315.","DOI":"10.1016\/B978-0-12-374203-2.00091-9"},{"key":"i2164-2591-8-5-15-b15","doi-asserted-by":"crossref","unstructured":"Patil\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSingh\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tOpere\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDash\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tSustained-release delivery system of a slow hydrogen sulfide donor, GYY 4137, for potential application in glaucoma.\n\t\t\t\t\tAAPS PharmSciTech.\n\t\t\t\t\t2017;\n\t\t\t\t\t18:\n\t\t\t\t\t2291\u20132302.","DOI":"10.1208\/s12249-017-0712-6"},{"key":"i2164-2591-8-5-15-b16","unstructured":"New Medical Therapies for Glaucoma.\n\t\t\t\t\thttps:\/\/www.glaucoma.org\/news\/blog\/new-medical-therapies-offer-hope-for-glaucoma-patients.php. Published March 6, 2018."},{"key":"i2164-2591-8-5-15-b17","doi-asserted-by":"crossref","unstructured":"Schehlein\n\t\t\t\t\t\t\tEM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNovack\n\t\t\t\t\t\t\tG,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRobin\n\t\t\t\t\t\t\tAL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tNew pharmacotherapy for the treatment of glaucoma.\n\t\t\t\t\tExpert Opin Pharmacother.\n\t\t\t\t\t2017;\n\t\t\t\t\t18:\n\t\t\t\t\t1939\u20131946.","DOI":"10.1080\/14656566.2017.1408791"},{"key":"i2164-2591-8-5-15-b18","doi-asserted-by":"crossref","unstructured":"Twitchell\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBrown\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMackie\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCannabinoids inhibit N- and P\/Q-type calcium channels in cultured rat hippocampal neurons.\n\t\t\t\t\tJ Neurophysiol.\n\t\t\t\t\t1997;\n\t\t\t\t\t78:\n\t\t\t\t\t43\u201350.","DOI":"10.1152\/jn.1997.78.1.43"},{"key":"i2164-2591-8-5-15-b19","doi-asserted-by":"crossref","unstructured":"Malinowska\n\t\t\t\t\t\t\tB,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGodlewski\n\t\t\t\t\t\t\tG,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBucher\n\t\t\t\t\t\t\tB,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSchlicker\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.\n\t\t\t\t\tNaunyn Schmiedebergs Arch Pharmacol.\n\t\t\t\t\t1997;\n\t\t\t\t\t356:\n\t\t\t\t\t197\u2013202.","DOI":"10.1007\/PL00005041"},{"key":"i2164-2591-8-5-15-b20","doi-asserted-by":"crossref","unstructured":"Sugrue\n\t\t\t\t\t\t\tMF.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tNew approaches to antiglaucoma therapy.\n\t\t\t\t\tJ Med Chem.\n\t\t\t\t\t1997;\n\t\t\t\t\t40:\n\t\t\t\t\t2793\u20132809.","DOI":"10.1021\/jm9608725"},{"key":"i2164-2591-8-5-15-b21","doi-asserted-by":"crossref","unstructured":"Allingham\n\t\t\t\t\t\t\tRR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tde Kater\n\t\t\t\t\t\t\tAW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEthier\n\t\t\t\t\t\t\tRC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tSchlemm's canal and primary open angle glaucoma: correlation between Schlemm's canal dimensions and outflow facility.\n\t\t\t\t\tExp Eye Res.\n\t\t\t\t\t1996;\n\t\t\t\t\t62:\n\t\t\t\t\t101\u2013110.","DOI":"10.1006\/exer.1996.0012"},{"key":"i2164-2591-8-5-15-b22","doi-asserted-by":"crossref","unstructured":"Tomida\n\t\t\t\t\t\t\tI,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPertwee\n\t\t\t\t\t\t\tRG,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAzuara-Blanco\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCannabinoids and glaucoma.\n\t\t\t\t\tBr J Ophthalmol.\n\t\t\t\t\t2004;\n\t\t\t\t\t88:\n\t\t\t\t\t708\u2013713.","DOI":"10.1136\/bjo.2003.032250"},{"key":"i2164-2591-8-5-15-b23","doi-asserted-by":"crossref","unstructured":"Panahi\n\t\t\t\t\t\t\tY,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tManayi\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNikan\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVazirian\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe arguments for and against cannabinoids application in glaucomatous retinopathy.\n\t\t\t\t\tBiomed Pharmacother.\n\t\t\t\t\t2016;\n\t\t\t\t\t86:\n\t\t\t\t\t620\u2013627.","DOI":"10.1016\/j.biopha.2016.11.106"},{"key":"i2164-2591-8-5-15-b24","doi-asserted-by":"crossref","unstructured":"Porcella\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaxia\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGessa\n\t\t\t\t\t\t\tGL,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPani\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein.\n\t\t\t\t\tEur J Neurosci.\n\t\t\t\t\t2000;\n\t\t\t\t\t12:\n\t\t\t\t\t1123\u20131127.","DOI":"10.1046\/j.1460-9568.2000.01027.x"},{"key":"i2164-2591-8-5-15-b25","doi-asserted-by":"crossref","unstructured":"Porcella\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaxia\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGessa\n\t\t\t\t\t\t\tGL,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPani\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies.\n\t\t\t\t\tEur J Neurosci.\n\t\t\t\t\t2001;\n\t\t\t\t\t13:\n\t\t\t\t\t409\u2013412.","DOI":"10.1046\/j.0953-816X.2000.01401.x"},{"key":"i2164-2591-8-5-15-b26","doi-asserted-by":"crossref","unstructured":"Morgan-Davies\n\t\t\t\t\t\t\tJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaylor\n\t\t\t\t\t\t\tN,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHill\n\t\t\t\t\t\t\tAR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAspinall\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tO'Brien\n\t\t\t\t\t\t\tCJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAzuara-Blanco\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThree dimensional analysis of the lamina cribrosa in glaucoma.\n\t\t\t\t\tBr J Ophthalmol.\n\t\t\t\t\t2004;\n\t\t\t\t\t88:\n\t\t\t\t\t1299\u20131304.","DOI":"10.1136\/bjo.2003.036020"},{"key":"i2164-2591-8-5-15-b27","doi-asserted-by":"crossref","unstructured":"Agarwal\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGupta\n\t\t\t\t\t\t\tSK,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAgarwal\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSaxena\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAgrawal\n\t\t\t\t\t\t\tSS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCurrent concepts in the pathophysiology of glaucoma.\n\t\t\t\t\tIndian J Ophthalmol.\n\t\t\t\t\t2009;\n\t\t\t\t\t57:\n\t\t\t\t\t257\u2013266.","DOI":"10.4103\/0301-4738.53049"},{"key":"i2164-2591-8-5-15-b28","doi-asserted-by":"crossref","unstructured":"Abe\n\t\t\t\t\t\t\tRY,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGracitelli\n\t\t\t\t\t\t\tCPB,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDiniz-Filho\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTatham\n\t\t\t\t\t\t\tAJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMedeiros\n\t\t\t\t\t\t\tFA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tLamina cribrosa in glaucoma: diagnosis and monitoring.\n\t\t\t\t\tCurr Ophthalmol Rep.\n\t\t\t\t\t2015;\n\t\t\t\t\t3:\n\t\t\t\t\t74\u201384.","DOI":"10.1007\/s40135-015-0067-7"},{"key":"i2164-2591-8-5-15-b29","doi-asserted-by":"crossref","unstructured":"Almasieh\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilson\n\t\t\t\t\t\t\tAM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMorquette\n\t\t\t\t\t\t\tB,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCueva Vargas\n\t\t\t\t\t\t\tJL,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDi Polo\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe molecular basis of retinal ganglion cell death in glaucoma.\n\t\t\t\t\tProg Retin Eye Res.\n\t\t\t\t\t2012;\n\t\t\t\t\t31:\n\t\t\t\t\t152\u2013181.","DOI":"10.1016\/j.preteyeres.2011.11.002"},{"key":"i2164-2591-8-5-15-b30","doi-asserted-by":"crossref","unstructured":"El-Remessy\n\t\t\t\t\t\t\tAB,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhalil\n\t\t\t\t\t\t\tIE,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMatragoon\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tNeuroprotective effect of(-)?9-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.\n\t\t\t\t\tAm J Pathol.\n\t\t\t\t\t2003:\n\t\t\t\t\t1997\u20132008.","DOI":"10.1016\/S0002-9440(10)63558-4"},{"key":"i2164-2591-8-5-15-b31","unstructured":"Ko\n\t\t\t\t\t\t\tML,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHu\n\t\t\t\t\t\t\tDN,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRitch\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSharma\n\t\t\t\t\t\t\tSC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tThe combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma.\n\t\t\t\t\tInvest Ophthalmol Vis Sci.\n\t\t\t\t\t2000;\n\t\t\t\t\t41:\n\t\t\t\t\t2967\u20132971."},{"key":"i2164-2591-8-5-15-b32","doi-asserted-by":"crossref","unstructured":"Naveh\n\t\t\t\t\t\t\tN,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWeissman\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMuchtar\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBenita\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMechoulam\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tA submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits.\n\t\t\t\t\tGraefes Arch Clin Ophthalmol.\n\t\t\t\t\t2000;\n\t\t\t\t\t238:\n\t\t\t\t\t334\u2013338.","DOI":"10.1007\/s004170050361"},{"key":"i2164-2591-8-5-15-b33","doi-asserted-by":"crossref","unstructured":"Shohami\n\t\t\t\t\t\t\tE,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGallily\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMechoulam\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBass\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBen-Hur\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-a inhibitor and an effective neuroprotectant.\n\t\t\t\t\tJ Neuroimmunol.\n\t\t\t\t\t1997;\n\t\t\t\t\t72:\n\t\t\t\t\t169\u2013177.","DOI":"10.1016\/S0165-5728(96)00181-6"},{"key":"i2164-2591-8-5-15-b34","doi-asserted-by":"crossref","unstructured":"Crandall\n\t\t\t\t\t\t\tJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMatragoon\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhalifa\n\t\t\t\t\t\t\tYM,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tNeuroprotective and intraocular pressure-lowering effects of (\u2013)d9-tetrahydrocannabinol in a rat model of glaucoma.\n\t\t\t\t\tOphthalmic Res.\n\t\t\t\t\t2007;\n\t\t\t\t\t39:\n\t\t\t\t\t69\u201375.","DOI":"10.1159\/000099240"},{"key":"i2164-2591-8-5-15-b35","doi-asserted-by":"crossref","unstructured":"Crandall\n\t\t\t\t\t\t\tJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMatragoon\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhalifa\n\t\t\t\t\t\t\tYM,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tNeuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.\n\t\t\t\t\tOphthalmic Res.\n\t\t\t\t\t2007;\n\t\t\t\t\t39:\n\t\t\t\t\t69\u201375.","DOI":"10.1159\/000099240"},{"key":"i2164-2591-8-5-15-b36","unstructured":"Grotenhermen\n\t\t\t\t\t\t\tF,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRusso\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.\n\t\t\t\t\tNew York:\n\t\t\t\t\tHaworth Integrative Healing Press;\n\t\t\t\t\t2002."},{"key":"i2164-2591-8-5-15-b37","doi-asserted-by":"crossref","unstructured":"Hepler\n\t\t\t\t\t\t\tRS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFrank\n\t\t\t\t\t\t\tIR.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tMarihuana smoking and intraocular pressure.\n\t\t\t\t\tJAMA\n\t\t\t\t\t1971;\n\t\t\t\t\t217:\n\t\t\t\t\t1392.","DOI":"10.1001\/jama.1971.03190100074024"},{"key":"i2164-2591-8-5-15-b38","doi-asserted-by":"crossref","unstructured":"Green\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tMarijuana smoking vs cannabinoids for glaucoma therapy.\n\t\t\t\t\tArch Ophthalmol.\n\t\t\t\t\t1998;\n\t\t\t\t\t116:\n\t\t\t\t\t1433\u20131437.","DOI":"10.1001\/archopht.116.11.1433"},{"key":"i2164-2591-8-5-15-b39","unstructured":"Crawford\n\t\t\t\t\t\t\tWJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMerritt\n\t\t\t\t\t\t\tJC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tEffects of tetrahydrocannabinol on arterial and intraocular hypertension.\n\t\t\t\t\tInt J Clin Pharmacol Biopharm.\n\t\t\t\t\t1979;\n\t\t\t\t\t17:\n\t\t\t\t\t191\u2013196."},{"key":"i2164-2591-8-5-15-b40","doi-asserted-by":"crossref","unstructured":"Merritt\n\t\t\t\t\t\t\tJC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPerry\n\t\t\t\t\t\t\tDD,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRussell\n\t\t\t\t\t\t\tDN,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJones\n\t\t\t\t\t\t\tBF.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tTopical ?9-tetrahydrocannabinol and aqueous dynamics in glaucoma.\n\t\t\t\t\tJ Clin Pharmacol.\n\t\t\t\t\t1981;\n\t\t\t\t\t21:\n\t\t\t\t\t467S\u2013471S.","DOI":"10.1002\/j.1552-4604.1981.tb02626.x"},{"key":"i2164-2591-8-5-15-b41","doi-asserted-by":"crossref","unstructured":"Elsohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHarland\n\t\t\t\t\t\t\tE,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMurphy\n\t\t\t\t\t\t\tJC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWirth\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWaller\n\t\t\t\t\t\t\tCW.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCannabinoids in glaucoma: a primary screening procedure.\n\t\t\t\t\tJ Clin Pharmacol.\n\t\t\t\t\t1981;\n\t\t\t\t\t21:\n\t\t\t\t\t472S\u2013478S.","DOI":"10.1002\/j.1552-4604.1981.tb02627.x"},{"key":"i2164-2591-8-5-15-b42","doi-asserted-by":"crossref","unstructured":"Jay\n\t\t\t\t\t\t\tWM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGreen\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tMultiple-drop study of topically applied 1% d9-tetrahydrocannabinol in human eyes.\n\t\t\t\t\tArch Ophthalmol.\n\t\t\t\t\t1983;\n\t\t\t\t\t101:\n\t\t\t\t\t591\u2013593.","DOI":"10.1001\/archopht.1983.01040010591012"},{"key":"i2164-2591-8-5-15-b43","doi-asserted-by":"crossref","unstructured":"Muchtar\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAlmog\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTorracca\n\t\t\t\t\t\t\tMT,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSaettone\n\t\t\t\t\t\t\tMF,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBenita\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tA submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.\n\t\t\t\t\tOphthalmic Res.\n\t\t\t\t\t1992;\n\t\t\t\t\t24:\n\t\t\t\t\t142\u2013149.","DOI":"10.1159\/000267160"},{"key":"i2164-2591-8-5-15-b44","unstructured":"Song\n\t\t\t\t\t\t\tZ-H,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSlowey\n\t\t\t\t\t\t\tC-A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tInvolvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.\n\t\t\t\t\tJ PharmacolExp Ther.\n\t\t\t\t\t2000;\n\t\t\t\t\t292:\n\t\t\t\t\t136\u2013139."},{"key":"i2164-2591-8-5-15-b45","doi-asserted-by":"crossref","unstructured":"ElSohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGul\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWalker\n\t\t\t\t\t\t\tLA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tPharmacokinetics and tolerability of ?9-THC-Hemisuccinate in a suppository formulation as an alternative to capsules for the systemic delivery of ?9-THC.\n\t\t\t\t\tMed Cannabis Cannabinoids.\n\t\t\t\t\t2018;\n\t\t\t\t\t1:\n\t\t\t\t\t44\u201353.","DOI":"10.1159\/000489037"},{"key":"i2164-2591-8-5-15-b46","doi-asserted-by":"crossref","unstructured":"Taskar\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdelli\n\t\t\t\t\t\t\tG,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPatil\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tAnalog derivatization of cannabidiol for improved ocular permeation.\n\t\t\t\t\tJ Ocul Pharmacol Ther.\n\t\t\t\t\t2019;\n\t\t\t\t\t35:\n\t\t\t\t\t301\u2013310.","DOI":"10.1089\/jop.2018.0141"},{"key":"i2164-2591-8-5-15-b47","doi-asserted-by":"crossref","unstructured":"Taskar\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTatke\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tAdvances in the use of prodrugs for drug delivery to the eye.\n\t\t\t\t\tExpert Opin Drug Deliv.\n\t\t\t\t\t2017;\n\t\t\t\t\t14:\n\t\t\t\t\t49\u201363.","DOI":"10.1080\/17425247.2016.1208649"},{"key":"i2164-2591-8-5-15-b48","doi-asserted-by":"crossref","unstructured":"Punyamurthula\n\t\t\t\t\t\t\tNS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdelli\n\t\t\t\t\t\t\tGR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGul\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElSohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tOcular disposition of 8-tetrahydrocannabinol from various topical ophthalmic formulations.\n\t\t\t\t\tAAPS PharmSciTech.\n\t\t\t\t\t2016;\n\t\t\t\t\t18:\n\t\t\t\t\t1936\u20131945.","DOI":"10.1208\/s12249-016-0672-2"},{"key":"i2164-2591-8-5-15-b49","unstructured":"ElSohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGul\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCompositions containing delta-9-THC-amino acid esters and process of preparation.\n\t\t\t\t\tGoogle Patents, US Patent number US8809261B2;\n\t\t\t\t\t2011."},{"key":"i2164-2591-8-5-15-b50","doi-asserted-by":"crossref","unstructured":"Schubert\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tM\u00fcller-Goymann\n\t\t\t\t\t\t\tCC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCharacterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.\n\t\t\t\t\tEur J Pharm Biopharm.\n\t\t\t\t\t2005;\n\t\t\t\t\t61:\n\t\t\t\t\t77\u201386.","DOI":"10.1016\/j.ejpb.2005.03.006"},{"key":"i2164-2591-8-5-15-b51","doi-asserted-by":"crossref","unstructured":"Green\n\t\t\t\t\t\t\tK,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBigger\n\t\t\t\t\t\t\tJF,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKim\n\t\t\t\t\t\t\tK,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBowman\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCannabinoid penetration and chronic effects in the eye.\n\t\t\t\t\tExp Eye Res.\n\t\t\t\t\t1977;\n\t\t\t\t\t24:\n\t\t\t\t\t197\u2013205.","DOI":"10.1016\/0014-4835(77)90260-3"},{"key":"i2164-2591-8-5-15-b52","doi-asserted-by":"crossref","unstructured":"Hingorani\n\t\t\t\t\t\t\tT,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdelli\n\t\t\t\t\t\t\tGR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPunyamurthula\n\t\t\t\t\t\t\tN,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tOcular disposition of the hemiglutarate ester prodrug of ?9-tetrahydrocannabinol from various ophthalmic formulations.\n\t\t\t\t\tPharm Res.\n\t\t\t\t\t2013;\n\t\t\t\t\t30.","DOI":"10.1007\/s11095-013-1072-x"},{"key":"i2164-2591-8-5-15-b53","doi-asserted-by":"crossref","unstructured":"Maurice\n\t\t\t\t\t\t\tDM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMishima\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tOcular pharmacokinetics.\n\t\t\t\t\tIn:\n\t\t\t\t\tSears ML ed, Pharmacology of the Eye.\n\t\t\t\t\tBerlin Heidelberg:\n\t\t\t\t\tSpringer;\n\t\t\t\t\t1984:\n\t\t\t\t\t19\u2013116.","DOI":"10.1007\/978-3-642-69222-2_2"},{"key":"i2164-2591-8-5-15-b54","doi-asserted-by":"crossref","unstructured":"Balguri\n\t\t\t\t\t\t\tSP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdelli\n\t\t\t\t\t\t\tGR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tTopical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.\n\t\t\t\t\tEur J Pharm Biopharm.\n\t\t\t\t\t2016;\n\t\t\t\t\t109:\n\t\t\t\t\t224\u2013235.","DOI":"10.1016\/j.ejpb.2016.10.015"},{"key":"i2164-2591-8-5-15-b55","doi-asserted-by":"crossref","unstructured":"Hingorani\n\t\t\t\t\t\t\tT,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGul\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElsohly\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tEffect of ion pairing on in vitro transcorneal permeability of a Delta(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.\n\t\t\t\t\tJ Pharm Sci.\n\t\t\t\t\t2011;\n\t\t\t\t\t101:\n\t\t\t\t\t616\u2013626.","DOI":"10.1002\/jps.22791"},{"key":"i2164-2591-8-5-15-b56","doi-asserted-by":"crossref","unstructured":"Thumma\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElSohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGul\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tPreformulation studies of a prodrug of d9-tetrahydrocannabinol.\n\t\t\t\t\tAAPS PharmSciTech.\n\t\t\t\t\t2008;\n\t\t\t\t\t9:\n\t\t\t\t\t982\u2013990.","DOI":"10.1208\/s12249-008-9136-7"},{"key":"i2164-2591-8-5-15-b57","doi-asserted-by":"crossref","unstructured":"Duvvuri\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMitra\n\t\t\t\t\t\t\tAK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tDrug delivery to the retina: challenges and opportunities.\n\t\t\t\t\tExpert Opin Biol Ther.\n\t\t\t\t\t2003;\n\t\t\t\t\t3:\n\t\t\t\t\t45\u201356.","DOI":"10.1517\/14712598.3.1.45"},{"key":"i2164-2591-8-5-15-b58","doi-asserted-by":"crossref","unstructured":"Kaur\n\t\t\t\t\t\t\tIP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKakkar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tNanotherapy for posterior eye diseases.\n\t\t\t\t\tJ Control Release.\n\t\t\t\t\t2014;\n\t\t\t\t\t193:\n\t\t\t\t\t100\u2013112.","DOI":"10.1016\/j.jconrel.2014.05.031"},{"key":"i2164-2591-8-5-15-b59","doi-asserted-by":"crossref","unstructured":"Patil\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLakhani\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaskar\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tFormulation development, optimization, and in-vitro characterization of natamycin-loaded PEGylated nano-lipid carriers for ocular applications.\n\t\t\t\t\tJ Pharm Sci.\n\t\t\t\t\t2018;\n\t\t\t\t\t107:\n\t\t\t\t\t2160\u20132171.","DOI":"10.1016\/j.xphs.2018.04.014"},{"key":"i2164-2591-8-5-15-b60","doi-asserted-by":"crossref","unstructured":"Lakhani\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPatil\n\t\t\t\t\t\t\tA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaskar\n\t\t\t\t\t\t\tP,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAshour\n\t\t\t\t\t\t\tE,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMajumdar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tCurcumin-loaded nanostructured lipid carriers for ocular drug delivery: design optimization and characterization.\n\t\t\t\t\tJ Drug Deliv Sci Technol.\n\t\t\t\t\t2018;\n\t\t\t\t\t47:\n\t\t\t\t\t159\u2013166.","DOI":"10.1016\/j.jddst.2018.07.010"},{"key":"i2164-2591-8-5-15-b61","doi-asserted-by":"crossref","unstructured":"Thumma\n\t\t\t\t\t\t\tS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElSohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhang\n\t\t\t\t\t\t\tSQ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGul\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tInfluence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices.\n\t\t\t\t\tEur J Pharm Biopharm.\n\t\t\t\t\t2008;\n\t\t\t\t\t70:\n\t\t\t\t\t605\u2013614.","DOI":"10.1016\/j.ejpb.2008.06.009"},{"key":"i2164-2591-8-5-15-b62","doi-asserted-by":"crossref","unstructured":"Munjal\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElSohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tChemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: Role of microenvironment pH.\n\t\t\t\t\tAAPS PharmSciTech.\n\t\t\t\t\t2006;\n\t\t\t\t\t7:\n\t\t\t\t\tE114\u2013E125.","DOI":"10.1208\/pt070371"},{"key":"i2164-2591-8-5-15-b63","doi-asserted-by":"crossref","unstructured":"Munjal\n\t\t\t\t\t\t\tM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElsohly\n\t\t\t\t\t\t\tMA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRepka\n\t\t\t\t\t\t\tMA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tPolymeric systems for amorphous d9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability.\n\t\t\t\t\tJ Pharm Sci.\n\t\t\t\t\t2006;\n\t\t\t\t\t95:\n\t\t\t\t\t2473\u20132485.","DOI":"10.1002\/jps.20711"},{"key":"i2164-2591-8-5-15-b64","doi-asserted-by":"crossref","unstructured":"Punyamurthula\n\t\t\t\t\t\t\tNS,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHingorani\n\t\t\t\t\t\t\tT,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdelli\n\t\t\t\t\t\t\tG,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tControlled release tablet formulation containing natural Delta(9)-tetrahydrocannabinol.\n\t\t\t\t\tDrug Dev Ind Pharm.\n\t\t\t\t\t2015;\n\t\t\t\t\t42:\n\t\t\t\t\t1158\u20131164.","DOI":"10.3109\/03639045.2015.1118490"},{"key":"i2164-2591-8-5-15-b65","doi-asserted-by":"crossref","unstructured":"Lizunova\n\t\t\t\t\t\t\tAA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLoshkarev\n\t\t\t\t\t\t\tAA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTokunov\n\t\t\t\t\t\t\tYM,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIvanov\n\t\t\t\t\t\t\tVV.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tComparison of the results of measurements of the sizes of nanoparticles in stable colloidal solutions by the methods of acoustic spectroscopy, dynamic light scattering, and transmission electron microscopy.\n\t\t\t\t\tMeas Tech.\n\t\t\t\t\t2017;\n\t\t\t\t\t59:\n\t\t\t\t\t1151\u20131155.","DOI":"10.1007\/s11018-017-1107-5"},{"key":"i2164-2591-8-5-15-b66","doi-asserted-by":"crossref","unstructured":"Anderson\n\t\t\t\t\t\t\tW,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKozak\n\t\t\t\t\t\t\tD,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tColeman\n\t\t\t\t\t\t\tVA,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJ\u00e4mting\n\t\t\t\t\t\t\t\u00c5K,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTrau\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tA comparative study of submicron particle sizing platforms: accuracy, precision and resolution analysis of polydisperse particle size distributions.\n\t\t\t\t\tJ Colloid Interface Sci.\n\t\t\t\t\t2013;\n\t\t\t\t\t405:\n\t\t\t\t\t322\u2013330.","DOI":"10.1016\/j.jcis.2013.02.030"},{"key":"i2164-2591-8-5-15-b67","doi-asserted-by":"crossref","unstructured":"Freitas\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tM\u00fcller\n\t\t\t\t\t\t\tRH.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN\u2122) dispersions.\n\t\t\t\t\tInt J Pharm.\n\t\t\t\t\t1998;\n\t\t\t\t\t168:\n\t\t\t\t\t221\u2013229.","DOI":"10.1016\/S0378-5173(98)00092-1"},{"key":"i2164-2591-8-5-15-b68","unstructured":"Goldman\n\t\t\t\t\t\t\tJN,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKuwabara\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tHistopathology of corneal edema.\n\t\t\t\t\tInt Ophthalmol Clin.\n\t\t\t\t\t1968;\n\t\t\t\t\t8:\n\t\t\t\t\t561\u2013579."},{"key":"i2164-2591-8-5-15-b69","doi-asserted-by":"crossref","unstructured":"Wang\n\t\t\t\t\t\t\tJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tXia\n\t\t\t\t\t\t\tQ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tAlpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro.\n\t\t\t\t\tDrug Deliv.\n\t\t\t\t\t2014;\n\t\t\t\t\t21:\n\t\t\t\t\t328\u2013341.","DOI":"10.3109\/10717544.2013.846435"},{"key":"i2164-2591-8-5-15-b70","doi-asserted-by":"crossref","unstructured":"Montenegro\n\t\t\t\t\t\t\tL,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tParenti\n\t\t\t\t\t\t\tC,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTurnaturi\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPasquinucci\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tResveratrol-loaded lipid nanocarriers: correlation between in vitro occlusion factor and in vivo skin hydrating effect.\n\t\t\t\t\tPharmaceutics.\n\t\t\t\t\t2017;\n\t\t\t\t\t9:\n\t\t\t\t\t58.","DOI":"10.3390\/pharmaceutics9040058"},{"key":"i2164-2591-8-5-15-b71","doi-asserted-by":"crossref","unstructured":"Wang\n\t\t\t\t\t\t\tJ,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhao\n\t\t\t\t\t\t\tF,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLiu\n\t\t\t\t\t\t\tR,\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tNovel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.\n\t\t\t\t\tInt J Nanomedicine.\n\t\t\t\t\t2017;\n\t\t\t\t\t12:\n\t\t\t\t\t8115\u20138127.","DOI":"10.2147\/IJN.S139436"},{"key":"i2164-2591-8-5-15-b72","doi-asserted-by":"crossref","unstructured":"Sarpotdar\n\t\t\t\t\t\t\tPp,\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZatz\n\t\t\t\t\t\t\tJL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tPercutaneous Absorption enhancement by nonionic surfactants.\n\t\t\t\t\tDrug Dev Ind Pharm.\n\t\t\t\t\t1986;\n\t\t\t\t\t12:\n\t\t\t\t\t1625\u20131647.","DOI":"10.3109\/03639048609042599"}],"container-title":["Translational Vision Science &amp; Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2751570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T14:30:52Z","timestamp":1568903452000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2751570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9,3]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.8.5.15","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,13]]}}}